Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study (Q39632529)
Jump to navigation
Jump to search
scientific article published on 4 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study |
scientific article published on 4 April 2012 |
Statements
1 reference
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study (English)
1 reference
1 reference
Marta Pestrin
1 reference
Silvia Bessi
1 reference
Alessandro M Minisini
1 reference
Giovanna Masci
1 reference
Nicola Battelli
1 reference
Alberto Ravaioli
1 reference
Lorenzo Gianni
1 reference
Roberta Di Marsico
1 reference
Carlo Tondini
1 reference
Charles R Coombes
1 reference
Justin Stebbing
1 reference
Marc Buyse
1 reference
4 April 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference